Navigation Links
Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors
Date:11/29/2007

CAMBRIDGE, Mass., Nov. 29 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a privately held biotechnology company focused on the discovery and development of novel treatments for autoimmune disease and cancer, today announced the retirement of Steven C. Wheelwright, PhD from its Board of Directors and the addition of Robert Gay, PhD.

Dr. Wheelwright served as a Director at Merrimack since May 2006. He was recently named the President of Brigham Young University Hawaii and is stepping down due to his relocation. Most recently, Dr. Wheelwright served as a Baker Foundation Professor and Chairman of HBS Publishing at Harvard Business School, while serving on numerous boards including Merrimack.

"Steve was an invaluable resource for our Board and the management at Merrimack," said Gary Crocker, Chairman of Merrimack's Board of Directors. "He was an outstanding director that provided the Board and management with pharmaceutical and operations expertise. We congratulate him and wish him the best in his new position."

Dr. Gay joins Merrimack's board having served as the former Managing Director and Chairman of the Management Committee of Bain Capital. Bain Capital is one of the world's leading private equity firms with over $40 billion in capital with offices in the US, Asia and Europe. Prior to joining Bain, Dr. Gay held numerous high level positions including Executive Vice President of General Electric Credit Corporation's Capital Markets Group, Vice President in the Merchant Banking Group at Kidder Peabody, and Engagement Manager at the international consulting firm, McKinsey & Company.

"Bob Gay's extensive financial and management capabilities developed with leading companies such as Bain Capital and GE bring further experienced management perspective to our already distinguished board" said Mr. Crocker. "We are excited to have Bob on our team and feel that his insight from previous transactions, growth management, and organizational
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17 de septiembre de 2014  Cryoport, ... proveedor mundial de soluciones logísticas avanzadas criogénicas ... la vida, anunció hoy la contratación de ... con sede en Rótterdam, Países Bajos, para ... Europa en rápido crecimiento. Según los términos ...
(Date:9/17/2014)... September 17, 2014 The Pistoia ... to lowering the barriers to innovation in life ... appointment of Carmen Nitsche as Executive Director Business ... expand its global reach. , Carmen joins the ... President, Corporate Development. At Accelrys, she managed various ...
(Date:9/16/2014)... , Sept. 16, 2014  Biocom, the association ... science community, recognizes the 9 th Annual National ... value of IT technologies in improving our health care ... is one of the world,s most vibrant hubs ... to mobile health applications to genomic testing to remote ...
(Date:9/16/2014)... N.C. , Sept. 16, 2014 ... heart failure compound has been shown to be effective ... results demonstrate an alternative to intravenous infusions that could ... prodrugs. The data were presented yesterday at the Heart ... Scientific Meeting in Las Vegas . ...
Breaking Biology Technology:Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 2Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 3Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 4Cryoport contrata a Broekman Group para mejorar su apoyo operativo y logístico en Europa 5Pistoia Alliance Expands Business Development with Appointment of Carmen Nitsche 2Biocom Recognizes National Health IT Week 2Cardioxyl Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting 2
... (Amex:,SGN) has announced that the legendary Earvin "Magic" ... ambulatory heart testing with AFL,s,flagship choice, Signalife,s Fidelity ... the greatest basketball superstars of all time, Mr.,Johnson ... multiple,championships from college to the Los Angeles Lakers ...
... September 13, 2007 at the 14th, International Symposium on Hepatitis C ... ... Glasgow, Scotland, VALLEY COTTAGE, New York, September 6 XTL,Biopharmaceuticals ... a late breaker abstract, entitled "Potent Small Molecule HCV,Inhibitors Affecting NS5A-dependent ...
... They,ve gotten the science wrong. They,ve gotten the law wrong. Why ... we trust them ... Coalition for,Lifesaving Cures responded today as opponents of stem cell cures ... weeks. Said Donn Rubin, Chair of Missouri Coalition for Lifesaving ...
Cached Biology Technology:Legendary Earvin 'Magic' Johnson Joins AFL/Signalife Cardiovascular Protection Team 2Legendary Earvin 'Magic' Johnson Joins AFL/Signalife Cardiovascular Protection Team 3XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference 23 strikes, you're out? Refiling of Amendment to Change Constitution to Criminalize Stem Cell Cures Shows Trouble with Anti-Cures Cause 2
(Date:9/16/2014)... The fall marks a new school year, a new ... International Space Station. In September, SpaceX,s Dragon spacecraft is ... supplies and investigations as part of the company,s fourth ... cargo will be the third suite of research investigations ... in Space (CASIS). With the role of managing the ...
(Date:9/16/2014)... its extravagant, colorful tail feathers in courtship of a ... special camera developed by an engineer at Washington University ... fish choose their mates based on a similar display. ... Austin used a bioinspired polarization camera developed by Viktor ... at Washington University, to make the discovery. His camera ...
(Date:9/16/2014)... the Exxon Valdez spilled 11 million gallons of oil ... up another giant oil spill in the Gulf of ... the Journal of Consumer Research , news coverage ... instead of catalyzing changes in the way fossil fuels ... media coverage of these two events helped to resolve ...
Breaking Biology News(10 mins):CASIS research set for launch aboard SpaceX mission to space station 2CASIS research set for launch aboard SpaceX mission to space station 3Camera developed at WUSTL sheds light on mate choice of swordtail fish 2Exxon Valdez 2014: Does media coverage of manmade disasters contribute to consumer complacency? 2
... Danish research team leads the way for future biodiversity ... of threatened wildlife a lake water sample the size ... fauna. Global biodiversity is plummeting while biologists are ... remains a major challenge. The biologist toolset has changed little ...
... 17, 2011   Life Technologies Corporation ... the company has introduced its GeneArt® Algae Engineering ... expression systems for photosynthetic microalgae Chlamydomonas reinhardtii ... are model organisms for the study of photosynthesis, ...
... biological data from electronic tags, ear bone microchemistry and fisheries ... side of the Atlantic influences the other side. Bluefin ... precipitously since 1950, according to the study published today in ... model estimates the number of Atlantic bluefin tuna remaining in ...
Cached Biology News:A lake fauna in a shot-glass 2GeneArt® Algae Engineering Kits by Life Technologies™ 2GeneArt® Algae Engineering Kits by Life Technologies™ 3New study provides comprehensive view of the status of Atlantic bluefin tuna 2New study provides comprehensive view of the status of Atlantic bluefin tuna 3
Pendrin (H-195)...
Conveniently document gels, films and membranes with a high quality thermal printer. , Compact, footprint printer , Supplies 256 gray scale for high resolution, archive-quality thermal film prints...
... is a thermostable DNA polymerase purified from ... the procedures developed by Kaledin (1,2,3) for ... polymerase activity from thermophilic bacteria. Amplification of ... be achieved with this enzyme. The enzyme ...
... to Cytokeratin 5 / 6 Cytokeratin ... weight, basic type of cytokeratin expressed in ... layers of stratified epithelia as well as ... cells and mesothelioma. Cytokeratin 6 (56 kD) ...
Biology Products: